Replies to post #202385 on Avid Bioservices Inc (CDMO)

[InternetForumUser]

Dr. Yopp has a Poster Session:
General Poster Session B and Trials in Progress Poster Session B

BOARD C14
A phase II study of bavituximab and sorafenib in advanced hepatocellular carcinoma (HCC). (Abstract 345)
Presenting Author: Adam C. Yopp